LECANEMAB for Dementia alzheimer's type: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 128 adverse event reports in the FDA FAERS database where LECANEMAB was used for Dementia alzheimer's type.
Most Reported Side Effects for LECANEMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Amyloid related imaging abnormality-oedema/effusion | 39 | 22.8% | 5 | 25 |
| Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits | 29 | 17.0% | 5 | 17 |
| Infusion related reaction | 16 | 9.4% | 1 | 12 |
| Cerebral haemorrhage | 12 | 7.0% | 4 | 5 |
| Confusional state | 10 | 5.9% | 3 | 5 |
| Dizziness | 9 | 5.3% | 0 | 6 |
| Status epilepticus | 6 | 3.5% | 2 | 4 |
| Fall | 5 | 2.9% | 0 | 4 |
| Nausea | 5 | 2.9% | 1 | 3 |
| Pyrexia | 5 | 2.9% | 1 | 2 |
| Syncope | 5 | 2.9% | 0 | 5 |
Other Indications for LECANEMAB
Other Drugs Used for Dementia alzheimer's type
RIVASTIGMINE (2,781)
DONEPEZIL (2,313)
LECANEMAB-IRMB (1,473)
MEMANTINE (1,335)
GALANTAMINE (468)
BREXPIPRAZOLE (381)
DONANEMAB-AZBT (347)
ADUCANUMAB-AVWA (341)
EXELON (282)
QUETIAPINE (200)